Challenge Conventional ThinkingView Our Research
What We Do
Prescience Point Capital Management conducts in-depth investigations of public companies, which often uncover fraud, misleading business practices or significant valuation issues. Unlike conventional investment research, we spend months on our analysis, dig deep into a company’s numbers, speak to industry experts and conduct on-the-ground due diligence to form our views. Our investment opinions are based on verifiable facts, not management’s representation of those facts.
Sign up for report updates
Prescience Point Nominates Slate of Highly-Qualified Director Candidates for Election to MiMedx Board
Prescience Point nominates 4 highly-qualified candidates to the board of MiMedx Group that we believe will help the company realize its significant potential and move…
Confirming our earlier research report, Celadon Group Inc. agreed to pay $42.2 million to settle fraud charges brought by the Department of Justice and the…
March 6, 2019
Kellogg Company | Update 2
In our latest report on Kellogg Company we are reiterating and updating our thesis based on Kellogg’s Q4 18 results and FY 19 guidance.
January 8, 2019
MiMedx Group Inc. | MDXG
Prescience Point believes that MiMedx shares offer one of the most attractive investment opportunities we have ever identified. We are long MDXG.
November 19, 2018
Kellogg Company | K – Update
Q3'18 results indicate the financial reckoning we predicted for Kellogg in April is upon us, and gaining speed. Our conviction has never been higher. We remain short Kellogg.
August 15, 2018
Enphase Energy | ENPH – Update
Prescience Point has discovered numerous additional red flags and believes shares of Enphase Energy remain grossly overvalued.
July 25, 2018
Enphase Energy Inc. | ENPH
Enphase Energy's shares could fall 85% to $1.00 when investors realize the company' seemingly overnight turnaround is nothing but a sham. Prescience Point is short ENPH.